Analysis of the therapeutic effect of transanal endoscopic microsurgery on large rectal adenoma

Yongbo Zhang1, Peng Yu2, Peng Wang3

  • 1Department of General Surgery, The First Affiliated Hospital of Shandong, First Medical University and Shandong Provincial Qianfoshan Hospital, Key Laboratory of Metabolism and Gastrointestinal Tumor, The First Affiliated Hospital of Shandong, First Medical University, Key Laboratory of Laparoscopic Technology, The First Affiliated Hospital of Shandong First Medical University, Shandong Medicine and Health Key Laboratory of General Surgery, Jinan, China.

Abstract

Insights

Transanal endoscopic microsurgery (TEM) is effective for treating large rectal adenomas (LRAs), a pre-cancerous condition. While recurrence occurred in 25.97% of patients, positive margins were identified as a key risk factor.

Area of Science:

  • Gastroenterology
  • Surgical Oncology
  • Colorectal Surgery

Background:

  • Rectal adenoma is a pre-cancerous lesion.
  • Transanal endoscopic microsurgery (TEM) offers unique advantages for rectal adenoma treatment.
  • Limited reports exist on the therapeutic effects of large rectal adenoma (LRA) treatment.

Purpose of the Study:

  • To investigate the therapeutic value of TEM in treating large rectal adenomas (LRAs).

Main Methods:

  • Retrospective analysis of 85 patients with LRA (≥3 cm diameter) treated with TEM between 2007-2017.
  • Follow-up assessed wound healing, rectal stenosis, and adenoma recurrence.
  • Risk factors for recurrence and wound healing were analyzed using univariate and multivariate methods.

Main Results:

  • Three patients (3.90%) developed rectal stenosis.
  • After 2 years, 20 patients (25.97%) experienced recurrence, while 57 (74.03%) did not.
  • Positive surgical margins were identified as an independent risk factor for adenoma recurrence.

Conclusions:

  • Transanal endoscopic microsurgery (TEM) is a feasible treatment option for large rectal tumors in specialized centers.
  • Careful margin assessment is crucial for minimizing recurrence risk in LRA treatment.